• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antimicrob Resist Infect Control . Secondary attack rate following on-site isolation of patients with suspected COVID-19 in multiple-bed rooms

tetano

Editor, Senior Moderator
Antimicrob Resist Infect Control


. 2024 Jul 6;13(1):73.
doi: 10.1186/s13756-024-01430-4. Secondary attack rate following on-site isolation of patients with suspected COVID-19 in multiple-bed rooms

Silvio Ragozzino[SUP] #[/SUP][SUP] 1 [/SUP], Richard Kuehl[SUP] #[/SUP][SUP] 1 [/SUP], Karoline Leuzinger[SUP] 2 [/SUP], Pascal Schläpfer[SUP] 2 [/SUP], Pascal Urwyler[SUP] 1 [/SUP], Ana Durovic[SUP] 1 [/SUP], Sandra Zingg[SUP] 1 [/SUP], Matthias von Rotz[SUP] 1 [/SUP], Manuel Battegay[SUP] 1 [/SUP], Andreas F Widmer[SUP] 1 [/SUP], Hans H Hirsch[SUP] 1 2 3 [/SUP], Stefano Bassetti[SUP] 4 [/SUP], Sarah Tschudin-Sutter[SUP] 5 6 [/SUP]



Affiliations
Abstract

The implementation of isolation precautions for patients with suspected Coronavirus Disease 2019 (COVID-19) and pending test results is resource intensive. Due to the limited availability of single-bed rooms at our institution, we isolated patients with suspected COVID-19 together with patients without suspected COVID-19 on-site in multiple-bed rooms until SARS-CoV-2-test results were available. We evaluated the likelihood of SARS-CoV-2 transmission to individuals sharing the room with patients isolated on-site. This observational study was performed at the University Hospital Basel, Switzerland, from 03/20 - 11/20. Secondary attack rates were compared between patients hospitalized in multiple-bed rooms and exposed to individuals subjected to on-site isolation precautions (on-site isolation group), and patients exposed to individuals initially not identified as having COVID-19, and not placed under isolation precautions until the diagnosis was suspected (control group). Transmission events were confirmed by whole-genome sequencing. Among 1,218 patients with suspected COVID-19, 67 (5.5%) tested positive for SARS-CoV-2. Of these, 21 were isolated on-site potentially exposing 27 patients sharing the same room. Median contact time was 12 h (interquartile range 7-18 h). SARS-CoV-2 transmission was identified in none of the patients in the on-site isolation group vs. 10/63 (15.9%) in the control group (p = 0.03). Isolation on-site of suspected COVID-19-patients in multiple-bed rooms avoided single-room occupancy and subsequent in-hospital relocation for many patients without confirmed SARS-CoV-2-infection. The absence of secondary transmission among the exposed patients in the on-site isolation group allows for assessment of the risk/benefit ratio of this strategy given the limitation of a small sample size.

Keywords: COVID-19; Disease outbreaks; Droplet and contact precautions; Healthcare-associated COVID-19; Infection prevention and control; Isolation on site; SARS-CoV-2; Secondary attack rate; Shared rooms; Whole-genome sequencing.

 
Back
Top Bottom